Form D · Other
Abacus Bioscience Inc.
Sammamish, WA · CIK 0001964311
Offering snapshot reported Feb 3, 2023 · SEC filing
- Reported sold
- $4.41M Offering amount: $4.41M
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 19, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 3, 2023 | Initial | $4,413,591 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-472553
Source: Form D, filed Feb 3, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Will Canestero | Director |
| Jonathan Drachman | Director |
| Diane Hollenbaugh | Director |
| Che Leung Law | Director |
| Alan Wahl | Director, Executive, Promoter |
Issuer details
Industry: Other (See others in industry)
Address:
27213 Se 27 Th St.
Sammamish, WA, 98075
Sammamish, WA, 98075